The Infectious Disease Molecular Diagnostics Market was valued at USD 16.24 billion in 2024, and is projected to reach USD 20.15 billion by 2030, rising at a CAGR of 3.37%. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings. ![Infectious Disease Molecular Diagnostics Market]( "Infectious Disease Molecular Diagnostics Market")
Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies.
Technologies such as INAAT, mass spectroscopy, and ISH are advanced and have a low false-positive rate as compared to other traditional diagnostic tests. Advantages such as the cost-effectiveness and user-friendliness of this technology and the accuracy offered are estimated to increase the adoption of this technology.
The use of molecular diagnostics in research institutes is increasing. The use of techniques such as PCR, western blotting, and southern blotting is becoming common. Moreover, the spread of SARS-CoV-2 infection globally has led to an increase in research funding by governments as well as diagnostic companies to search for innovative molecular diagnostics.
Molecular diagnostics deliver effective and accurate results. Moreover, these tests enable the early detection of diseases, maintaining a low threat of substitutes. However, the high prices of these tests are expected to encourage patients to shift to external substitutes. Moreover, for the detection of newer infections such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry.
Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies.
Technologies such as INAAT, mass spectroscopy, and ISH are advanced and have a low false-positive rate as compared to other traditional diagnostic tests. Advantages such as the cost-effectiveness and user-friendliness of this technology and the accuracy offered are estimated to increase the adoption of this technology.
The use of molecular diagnostics in research institutes is increasing. The use of techniques such as PCR, western blotting, and southern blotting is becoming common. Moreover, the spread of SARS-CoV-2 infection globally has led to an increase in research funding by governments as well as diagnostic companies to search for innovative molecular diagnostics.
Molecular diagnostics deliver effective and accurate results. Moreover, these tests enable the early detection of diseases, maintaining a low threat of substitutes. However, the high prices of these tests are expected to encourage patients to shift to external substitutes. Moreover, for the detection of newer infections such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry.
Infectious Disease Molecular Diagnostics Market Report Highlights
- Reagents led the market with a 25.86% revenue share in 2024 and are projected to experience the fastest CAGR over the forecast period due to their widespread use in infectious disease diagnostics.
- Polymerase Chain Reaction (PCR) technology secured the dominant revenue share in 2024 owing to its widespread application in detecting a broad range of infectious diseases, including COVID-19, HIV, hepatitis, and tuberculosis.
- Respiratory diseases held the largest market share of 71.96% in 2024, driven primarily by the rising prevalence of respiratory infectious diseases such as Respiratory Syncytial Virus (RSV), influenza, COVID-19, etc.
- Diagnostic laboratories held the dominant revenue share in 2024, driven by the rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and respiratory infections, which require accurate and timely diagnosis.
- North America infectious disease molecular diagnosis market accounted for 40.95% of the revenue share in 2024, driven by the high prevalence of infectious diseases such as COVID-19, influenza, HIV, and hepatitis.
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Infectious Disease Molecular Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Infectious Disease Molecular Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Infectious Disease Molecular Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Infectious Disease Molecular Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Infectious Disease Molecular Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Instruments
4.3.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Reagents
4.4.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Services
4.5.1. Services Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2. Infectious Disease Molecular Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Instruments
4.3.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Reagents
4.4.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Services
4.5.1. Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Infectious Disease Molecular Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
5.3. Polymerase Chain Reaction (PCR)
5.3.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2. Multiplex PCR
5.3.2.1. Multiplex PCR Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2.2. Instruments
5.3.2.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2.3. Reagents
5.3.2.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2.4. Others
5.3.2.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.3. Other PCR
5.3.3.1.1. Other PCR Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4. In Situ Hybridization
5.4.1. In Situ Hybridization Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. Reagents
5.4.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.4. Others
5.4.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. Reagents
5.5.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.4. Others
5.5.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Chips and Microarrays
5.6.1. Chips and Microarrays Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.3. Reagents
5.6.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.4. Others
5.6.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Mass Spectrometry
5.7.1. Mass Spectrometry Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.3. Reagents
5.7.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.4. Others
5.7.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Sequencing
5.8.1. Sequencing Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.3. Reagents
5.8.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.4. Others
5.8.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9. Transcription Mediated Amplification
5.9.1. Transcription Mediated Amplification Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9.3. Reagents
5.9.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9.4. Others
5.9.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10. Others
5.10.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10.2. Instruments
5.10.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10.3. Reagents
5.10.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10.4. Others
5.10.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.2. Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
5.3. Polymerase Chain Reaction (PCR)
5.3.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2. Multiplex PCR
5.3.2.1. Multiplex PCR Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2.2. Instruments
5.3.2.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2.3. Reagents
5.3.2.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2.4. Others
5.3.2.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.3. Other PCR
5.3.3.1.1. Other PCR Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4. In Situ Hybridization
5.4.1. In Situ Hybridization Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. Reagents
5.4.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.4. Others
5.4.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. Reagents
5.5.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.4. Others
5.5.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Chips and Microarrays
5.6.1. Chips and Microarrays Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.3. Reagents
5.6.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.4. Others
5.6.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Mass Spectrometry
5.7.1. Mass Spectrometry Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.3. Reagents
5.7.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7.4. Others
5.7.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Sequencing
5.8.1. Sequencing Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.3. Reagents
5.8.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8.4. Others
5.8.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9. Transcription Mediated Amplification
5.9.1. Transcription Mediated Amplification Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9.3. Reagents
5.9.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.9.4. Others
5.9.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10. Others
5.10.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10.2. Instruments
5.10.2.1. Instruments Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10.3. Reagents
5.10.3.1. Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
5.10.4. Others
5.10.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Infectious Disease Molecular Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Infectious Disease Molecular Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
6.3. Respiratory Diseases
6.3.1. Respiratory Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Tuberculosis
6.4.1. Tuberculosis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Meningitis
6.5.1. Meningitis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Gastrointestinal Tract Infections
6.6.1. Gastrointestinal Tract Infections Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. HPV
6.7.1. HPV Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Sexually Transmitted Infections
6.8.1. Sexually Transmitted Infections Market Estimates and Forecasts, 2018-2030 (USD Million)
6.9. Sepsis
6.9.1. Sepsis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.10. Drug Resistance Diseases
6.10.1. Drug Resistance Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
6.11. Others
6.11.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
6.2. Infectious Disease Molecular Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
6.3. Respiratory Diseases
6.3.1. Respiratory Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Tuberculosis
6.4.1. Tuberculosis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Meningitis
6.5.1. Meningitis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Gastrointestinal Tract Infections
6.6.1. Gastrointestinal Tract Infections Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. HPV
6.7.1. HPV Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Sexually Transmitted Infections
6.8.1. Sexually Transmitted Infections Market Estimates and Forecasts, 2018-2030 (USD Million)
6.9. Sepsis
6.9.1. Sepsis Market Estimates and Forecasts, 2018-2030 (USD Million)
6.10. Drug Resistance Diseases
6.10.1. Drug Resistance Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
6.11. Others
6.11.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Infectious Disease Molecular Diagnostics Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Infectious Disease Molecular Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Clinics
7.4.1. Clinics Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Diagnostics Laboratories
7.5.1. Diagnostics Laboratories Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Research Institutes
7.6.1. Research Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
7.2. Infectious Disease Molecular Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Clinics
7.4.1. Clinics Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Diagnostics Laboratories
7.5.1. Diagnostics Laboratories Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Research Institutes
7.6.1. Research Institutes Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Infectious Disease Molecular Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Infectious Disease Molecular Diagnostics Market Share, by Region, 2024 & 2030 (USD Million)
8.2. North America
8.2.1. North America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3. Europe
8.3.1. Europe Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. France
8.3.4.1. France Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. China
8.4.3.1. China Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. India
8.4.4.1. India Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2. North America
8.2.1. North America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3. Europe
8.3.1. Europe Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. France
8.3.4.1. France Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. China
8.4.3.1. China Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. India
8.4.4.1. India Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Abbott
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Danaher Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. bioMérieux SA
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. F. Hoffmann-La Roche Ltd
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Bio-Rad Laboratories, Inc.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Agilent Technologies, Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Becton, Dickinson and Company
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Hologic, Inc. (Gen-Probe)
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Grifols S.A.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Qiagen
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Siemens Healthineers AG
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. Sysmex Corporation
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Abbott
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Danaher Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. bioMérieux SA
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. F. Hoffmann-La Roche Ltd
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Bio-Rad Laboratories, Inc.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Agilent Technologies, Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Becton, Dickinson and Company
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Hologic, Inc. (Gen-Probe)
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Grifols S.A.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Qiagen
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Siemens Healthineers AG
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. Sysmex Corporation
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global infectious disease molecular diagnostics market, by region, 2018-2030 (USD Million)
Table 3 Global infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 4 Global infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 5 Global infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 6 Global infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 7 North America infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 8 North America infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 9 North America infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 10 North America infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 11 North America infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 12 U.S. infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 13 U.S. infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 14 U.S. infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 15 U.S. infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 16 Canada infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 17 Canada infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 18 Canada infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 19 Canada infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 20 Mexico infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 21 Mexico infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 22 Mexico infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 23 Mexico infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 24 Europe infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 25 Europe infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 26 Europe infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 27 Europe infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 28 Europe infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 29 UK infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 30 UK infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 31 UK infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 32 UK infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 33 Germany infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 34 Germany infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 35 Germany infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 36 Germany infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 37 France infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 38 France infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 39 France infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 40 France infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 41 Italy infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 42 Italy infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 43 Italy infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 44 Italy infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 45 Spain infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 46 Spain infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 47 Spain infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 48 Spain infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 49 Denmark infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 50 Denmark infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 51 Denmark infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 52 Denmark infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 53 Sweden infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 54 Sweden infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 55 Sweden infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 56 Sweden infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 57 Norway infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 58 Norway infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 59 Norway infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 60 Norway infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 61 Asia Pacific infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 63 Asia Pacific infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 64 Asia Pacific infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 65 Asia Pacific infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 66 Japan infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 67 Japan infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 68 Japan infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 69 Japan infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 70 China infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 71 China infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 72 China infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 73 China infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 74 India infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 75 India infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 76 India infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 77 India infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 78 Australia infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 79 Australia infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 80 Australia infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 81 Australia infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 82 South Korea infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 83 South Korea infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 84 South Korea infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 85 South Korea infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 86 Thailand infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 87 Thailand infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 88 Thailand infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 89 Thailand infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 90 Latin America infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 91 Latin America infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 92 Latin America infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 93 Latin America infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 94 Latin America infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 95 Brazil infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 96 Brazil infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 97 Brazil infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 98 Brazil infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 99 Argentina infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 100 Argentina infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 101 Argentina infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 102 Argentina infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 103 MEA infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 104 MEA infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 105 MEA infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 106 MEA infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 107 MEA infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 108 South Africa infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 109 South Africa infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 110 South Africa infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 111 South Africa infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 112 Saudi Arabia infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 113 Saudi Arabia infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 114 Saudi Arabia infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 115 Saudi Arabia infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 116 UAE infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 117 UAE infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 118 UAE infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 119 UAE infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 120 Kuwait infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 121 Kuwait infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 122 Kuwait infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 123 Kuwait infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 2 Global infectious disease molecular diagnostics market, by region, 2018-2030 (USD Million)
Table 3 Global infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 4 Global infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 5 Global infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 6 Global infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 7 North America infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 8 North America infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 9 North America infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 10 North America infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 11 North America infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 12 U.S. infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 13 U.S. infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 14 U.S. infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 15 U.S. infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 16 Canada infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 17 Canada infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 18 Canada infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 19 Canada infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 20 Mexico infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 21 Mexico infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 22 Mexico infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 23 Mexico infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 24 Europe infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 25 Europe infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 26 Europe infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 27 Europe infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 28 Europe infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 29 UK infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 30 UK infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 31 UK infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 32 UK infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 33 Germany infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 34 Germany infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 35 Germany infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 36 Germany infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 37 France infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 38 France infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 39 France infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 40 France infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 41 Italy infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 42 Italy infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 43 Italy infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 44 Italy infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 45 Spain infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 46 Spain infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 47 Spain infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 48 Spain infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 49 Denmark infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 50 Denmark infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 51 Denmark infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 52 Denmark infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 53 Sweden infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 54 Sweden infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 55 Sweden infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 56 Sweden infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 57 Norway infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 58 Norway infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 59 Norway infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 60 Norway infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 61 Asia Pacific infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 63 Asia Pacific infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 64 Asia Pacific infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 65 Asia Pacific infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 66 Japan infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 67 Japan infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 68 Japan infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 69 Japan infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 70 China infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 71 China infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 72 China infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 73 China infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 74 India infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 75 India infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 76 India infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 77 India infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 78 Australia infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 79 Australia infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 80 Australia infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 81 Australia infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 82 South Korea infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 83 South Korea infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 84 South Korea infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 85 South Korea infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 86 Thailand infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 87 Thailand infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 88 Thailand infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 89 Thailand infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 90 Latin America infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 91 Latin America infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 92 Latin America infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 93 Latin America infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 94 Latin America infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 95 Brazil infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 96 Brazil infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 97 Brazil infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 98 Brazil infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 99 Argentina infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 100 Argentina infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 101 Argentina infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 102 Argentina infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 103 MEA infectious disease molecular diagnostics market, by country, 2018-2030 (USD Million)
Table 104 MEA infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 105 MEA infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 106 MEA infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 107 MEA infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 108 South Africa infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 109 South Africa infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 110 South Africa infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 111 South Africa infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 112 Saudi Arabia infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 113 Saudi Arabia infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 114 Saudi Arabia infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 115 Saudi Arabia infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 116 UAE infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 117 UAE infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 118 UAE infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 119 UAE infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
Table 120 Kuwait infectious disease molecular diagnostics market, by product, 2018-2030 (USD Million)
Table 121 Kuwait infectious disease molecular diagnostics market, by technology, 2018-2030 (USD Million)
Table 122 Kuwait infectious disease molecular diagnostics market, by application, 2018-2030 (USD Million)
Table 123 Kuwait infectious disease molecular diagnostics market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Infectious disease molecular diagnostics market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Segment snapshot-2
Figure 15 Competitive landscape snapshot
Figure 16 Market trends & outlook
Figure 17 Porter’s five force analysis
Figure 18 PESTEL analysis
Figure 19 Infectious disease molecular diagnostics market: Product outlook key takeaways
Figure 20 Infectious disease molecular diagnostics market: Product movement analysis
Figure 21 Transfemoral market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Services market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Infectious disease molecular diagnostics market: Technology outlook key takeaways
Figure 26 Infectious disease molecular diagnostics market: Technology movement analysis
Figure 27 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 In Situ Hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Chips and Microarrays market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Mass Spectrometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Transcription Mediated Amplification market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Others market estimates and forecasts, 2018-2030 (USD Million) market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Multiplex PCR market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Other PCR market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Infectious disease molecular diagnostics market: Application outlook key takeaways
Figure 58 Infectious disease molecular diagnostics market: Application movement analysis
Figure 59 Respiratory Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Tuberculosis market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Meningitis market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Gastrointestinal Tract Infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 HPV market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 Sexually Transmitted Infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Sepsis market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Drug Resistance Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Infectious disease molecular diagnostics market: End use outlook key takeaways
Figure 69 Infectious disease molecular diagnostics market: End use movement analysis
Figure 70 Hospitals market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Clinics market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 Diagnostics Laboratories market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Research Institutes market estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Regional marketplace outlook, 2024 & 2030 (USD Million)
Figure 75 Regional marketplace: Key takeaways
Figure 76 North America infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 U.S. infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Canada infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 81 Key country dynamics
Figure 82 Mexico infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 83 Europe infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 UK infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 Germany infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 France infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 Spain infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Italy infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 Denmark infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 96 Key country dynamics
Figure 97 Sweden infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 98 Key country dynamics
Figure 99 Norway infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 100 Asia Pacific infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 101 Key country dynamics
Figure 102 Japan infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 103 Key country dynamics
Figure 104 China infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 105 Key country dynamics
Figure 106 India infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 107 Key country dynamics
Figure 108 Australia infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 109 Key country dynamics
Figure 110 South Korea infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 111 Key country dynamics
Figure 112 Thailand infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 113 Key country dynamics
Figure 114 Market participant categorization
Figure 115 Infectious disease molecular diagnostics market position analysis, 2023
Figure 116 Strategic framework
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Segment snapshot-2
Figure 15 Competitive landscape snapshot
Figure 16 Market trends & outlook
Figure 17 Porter’s five force analysis
Figure 18 PESTEL analysis
Figure 19 Infectious disease molecular diagnostics market: Product outlook key takeaways
Figure 20 Infectious disease molecular diagnostics market: Product movement analysis
Figure 21 Transfemoral market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Services market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Infectious disease molecular diagnostics market: Technology outlook key takeaways
Figure 26 Infectious disease molecular diagnostics market: Technology movement analysis
Figure 27 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 In Situ Hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Chips and Microarrays market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Mass Spectrometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Transcription Mediated Amplification market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Others market estimates and forecasts, 2018-2030 (USD Million) market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Multiplex PCR market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Other PCR market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Infectious disease molecular diagnostics market: Application outlook key takeaways
Figure 58 Infectious disease molecular diagnostics market: Application movement analysis
Figure 59 Respiratory Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Tuberculosis market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Meningitis market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Gastrointestinal Tract Infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 HPV market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 Sexually Transmitted Infections market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Sepsis market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Drug Resistance Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Infectious disease molecular diagnostics market: End use outlook key takeaways
Figure 69 Infectious disease molecular diagnostics market: End use movement analysis
Figure 70 Hospitals market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Clinics market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 Diagnostics Laboratories market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Research Institutes market estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Regional marketplace outlook, 2024 & 2030 (USD Million)
Figure 75 Regional marketplace: Key takeaways
Figure 76 North America infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 U.S. infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Canada infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 81 Key country dynamics
Figure 82 Mexico infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 83 Europe infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 UK infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 Germany infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 France infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 Spain infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Italy infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 Denmark infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 96 Key country dynamics
Figure 97 Sweden infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 98 Key country dynamics
Figure 99 Norway infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 100 Asia Pacific infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 101 Key country dynamics
Figure 102 Japan infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 103 Key country dynamics
Figure 104 China infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 105 Key country dynamics
Figure 106 India infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 107 Key country dynamics
Figure 108 Australia infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 109 Key country dynamics
Figure 110 South Korea infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 111 Key country dynamics
Figure 112 Thailand infectious disease molecular diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 113 Key country dynamics
Figure 114 Market participant categorization
Figure 115 Infectious disease molecular diagnostics market position analysis, 2023
Figure 116 Strategic framework
Companies Mentioned
The major companies profiled in this Infectious Disease Molecular Diagnostics market report include:- Abbott
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- F. Hoffmann-La Roche Ltd
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Hologic, Inc. (Gen-Probe)
- Illumina, Inc.
- Grifols S.A.
- Qiagen
- Siemens Healthineers AG
- Sysmex Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 16.24 Billion |
| Forecasted Market Value ( USD | $ 20.15 Billion |
| Compound Annual Growth Rate | 3.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
